Shunan Qi

1.6k total citations
65 papers, 938 citations indexed

About

Shunan Qi is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shunan Qi has authored 65 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pathology and Forensic Medicine, 37 papers in Oncology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shunan Qi's work include Lymphoma Diagnosis and Treatment (29 papers), Viral-associated cancers and disorders (21 papers) and Breast Cancer Treatment Studies (15 papers). Shunan Qi is often cited by papers focused on Lymphoma Diagnosis and Treatment (29 papers), Viral-associated cancers and disorders (21 papers) and Breast Cancer Treatment Studies (15 papers). Shunan Qi collaborates with scholars based in China, United States and Denmark. Shunan Qi's co-authors include Ye‐Xiong Li, Shulian Wang, Weihu Wang, Hui Fang, Zihao Yu, Joachim Yahalom, Xin-Fan Liu, Yue‐Ping Liu, Qingfeng Liu and Jing Jin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Shunan Qi

59 papers receiving 930 citations

Peers

Countries citing papers authored by Shunan Qi

Since Specialization

Citations

This map shows the geographic impact of Shunan Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shunan Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shunan Qi more than expected).

Fields of papers citing papers by Shunan Qi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shunan Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shunan Qi. The network helps show where Shunan Qi may publish in the future.

Co-authorship network of co-authors of Shunan Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Shunan Qi. A scholar is included among the top collaborators of Shunan Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shunan Qi. Shunan Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dosimetric benefit and clinical feasibility of deep inspiration breath-hold and volumetric modulated arc therapy-based postmastectomy radiotherapy for left-sided breast cancer 2024 ·Scientific Reports ·Shijia Wang, Yirui Zhai, Wen‐Wen Zhang, Siye Chen, (unknown), (unknown), Yu Tang, Yong-Wen Song, Yueping Liu, Bo Chen, Shunan Qi, (unknown), (unknown), Ye‐Xiong Li, Jing Hao, Shulian Wang	0
2	Results of a prospective phase II study of total neoadjuvant therapy for locally advanced rectal cancer. 2024 ·Journal of Clinical Oncology ·Huiying Ma, Yuan Tang, (unknown), Haitao Zhou, Zheng Liu, Haizeng Zhang, Yong Cai, Yongheng Li, Lichun Wei, Shixin Liu, (unknown), Yong-Wen Song, (unknown), Ning-Ning Lu, Shunan Qi, Yue‐Ping Liu, Shulian Wang, Xishan Wang, Ye‐Xiong Li, Jing Jin	0
3	Radiotherapy with Targeted Therapy or Immune Checkpoint Inhibitors for Hepatocellular Carcinoma with Hepatic Vein and/or Inferior Vena Cava Tumor Thrombi 2024 ·Journal of Hepatocellular Carcinoma ·Zhuoran Li, Yirui Zhai, Fan Wu, Da‐Yong Cao, Feng Ye, Yan Song, Shulian Wang, (unknown), Yong-Wen Song, Yuan Tang, Jing Hao, Hui Fang, Shunan Qi, (unknown), Ye‐Xiong Li, Jianxiong Wu, (unknown)	2
4	A prospective phase II clinical trial of total neoadjuvant therapy for locally advanced gastric cancer and gastroesophageal junction adenocarcinoma 2024 ·Scientific Reports ·Jinming Shi, Ning Li, Liming Jiang, Lin Yang, Shulian Wang, Yong-Wen Song, Yueping Liu, Hui Fang, Ning-Ning Lu, Shunan Qi, Bo Chen, Ye‐Xiong Li, Dongbing Zhao, Yuan Tang, Jing Jin	4
5	Voluntary Deep Inspiration Breath-Hold (VDIBH) Whole-Breast Irradiation Assisted by Optical Surface Monitoring System (OSMS) in Patients With Left-Sided Breast Cancer: A Prospective Phase II Study 2023 ·Technology in Cancer Research & Treatment ·(unknown), (unknown), (unknown), Zhiqiang Liu, Siye Chen, Yong-Wen Song, Yu Tang, Jing Hao, (unknown), Xu-Ran Zhao, (unknown), Yue‐Ping Liu, (unknown), Shunan Qi, Ning Li, (unknown), Ning-Ning Lu, Ye‐Xiong Li, Shulian Wang	1
6	Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac 2023 ·Frontiers in Oncology ·(unknown), Yuan Tian, (unknown), (unknown), (unknown), Yong-Wen Song, Shulian Wang, (unknown), Hui Fang, (unknown), Shunan Qi, (unknown), Yue‐Ping Liu, (unknown), Bo Chen, Nianzeng Xing, Ye‐Xiong Li, (unknown)	6
7	Tislelizumab and Radiation Therapy in Low-Risk Early-Stage Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Phase II Study Protocol 2023 ·Future Oncology ·(unknown), Shunan Qi, Chen Hu, Xin Liu, Yong Yang, Tao Wu, Rong Zheng, Xiaoli Feng, Xiao‐Guang Ni, Fengyan Jin, Yuqin Song, Weiping Liu, Shengyu Zhou, Ye‐Xiong Li	0
8	Impact of age on long-term relative survival benefit of radiotherapy for early-stage grade I–II follicular lymphoma from the SEER database (2000–2015) 2023 ·Leukemia & lymphoma ·(unknown), Ye Liu, Yunpeng Wu, Xin Liu, Siye Chen, Bo Chen, Fei Su, Gaofeng Li, Yonggang Xu, Lipin Liu, Fan Chen, Shunan Qi, Ye‐Xiong Li	1
9	Progression‐free survival at 3 years is a reliable surrogate for 5‐year overall survival for patients suffering from locally advanced esophageal squamous cell carcinoma 2022 ·Cancer Medicine ·(unknown), (unknown), Yuzhen Zheng, (unknown), Shiliang Liu, Mian Xi, Meng‐Zhong Liu, Junye Wang, Shunan Qi, Yong Yang, Lei Zhao	7
10	Adjuvant Chemoradiotherapy Versus Adjuvant Chemotherapy for Stage III Gastric or Gastroesophageal Junction Cancer After D2/R0 Resection 2022 ·Frontiers in Oncology ·Jinming Shi, Wenzhe Kang, Yuan Tang, Ning Li, Liming Jiang, Lin Yang, Shulian Wang, Yong-Wen Song, Yueping Liu, Hui Fang, (unknown), Shunan Qi, Bo Chen, Ye‐Xiong Li, (unknown), Jing Jin	0
11	Timing of postmastectomy radiotherapy following adjuvant chemotherapy for high-risk breast cancer: A post hoc analysis of a randomised controlled clinical trial 2022 ·European Journal of Cancer ·Siye Chen, (unknown), Yu Tang, Jing Hao, Yong-Wen Song, (unknown), Yue‐Ping Liu, Xu-Ran Zhao, (unknown), Bo Chen, Shunan Qi, Yuan Tang, Ning-Ning Lu, Ning Li, Hui Fang, Ye‐Xiong Li, Shulian Wang	4
12	Development and Validation of an MRI-Based Nomogram Model for Predicting Disease-Free Survival in Locally Advanced Rectal Cancer Treated With Neoadjuvant Radiotherapy 2021 ·Frontiers in Oncology ·Silin Chen, Yuan Tang, Ning Li, Jun Jiang, Liming Jiang, Bo Chen, Hui Fang, Shunan Qi, (unknown), Ning-Ning Lu, Shulian Wang, Yong-Wen Song, Yue‐Ping Liu, Ye‐Xiong Li, Jing Jin	1
13	Long-term outcomes of moderately hypofractionated radiotherapy (67.5 Gy in 25 fractions) for prostate cancer confined to the pelvis: a single center retrospective analysis 2020 ·Radiation Oncology ·Lihong Yao, Jianzhong Shou, Shulian Wang, Yong-Wen Song, Hui Fang, Ning-Ning Lu, Yuan Tang, Bo Chen, Shunan Qi, Yong Yang, Jing Hao, Jing Jin, Zihao Yu, Ye‐Xiong Li, Yue‐Ping Liu	4
14	Abnormal pretreatment coagulation factor levels correlate with poor prognosis in patients with early-stage extranodal nasal-type natural/killer T cell lymphoma 2020 ·Annals of Hematology ·(unknown), (unknown), Bo Chen, Lin Gui, Jianliang Yang, Shunan Qi, Yong-Wen Song, Ye‐Xiong Li, (unknown), Mei Dong	1
15	Predicting the risk of non-sentinel lymph node metastasis in breast cancer patients with 1-2 positive sentinel lymph nodes 2019 ·Zhonghua fangshe zhongliuxue zazhi ·Zhou Huang, Yu Tang, Shulian Wang, Yongwen Song, Jing Jin, (unknown), (unknown), Hao Jing, Jianyang Wang, Yueping Liu, Bo Chen, Shunan Qi, Ning Li, Yuan Tang, Ning-Ning Lu	1
16	Phase 2 Study of First-line Intensity Modulated Radiation Therapy Followed by Gemcitabine, Dexamethasone, and Cisplatin for High-Risk, Early Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: The GREEN Study 2018 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Weihu Wang, Xiaohui He, Bo Chen, Lin Gui, Hui Fang, Peng Liu, Shulian Wang, Jianliang Yang, Yongwen Song, Sheng Yang, Shunan Qi, Shengyu Zhou, Ye‐Xiong Li, Mei Dong	12
17	Radiotherapy Alone With Curative Intent in Patients With Stage I Extranodal Nasal-Type NK/T-Cell Lymphoma 2011 ·International Journal of Radiation OncologyBiologyPhysics ·Ye‐Xiong Li, Hua Wang, Jing Jin, Weihu Wang, Qingfeng Liu, Yongwen Song, Zhaoyang Wang, Shunan Qi, Shulian Wang, Yueping Liu, Xin-Fan Liu, Zihao Yu	69
18	The extent of cutaneous lesions predicts outcome in extranodal nasal-type natural killer/T-cell lymphoma of the upper aerodigestive tract with secondary cutaneous involvement 2011 ·Leukemia & lymphoma ·Shunan Qi, Ye‐Xiong Li, Weihu Wang, Jing Jin, Shulian Wang, Yue‐Ping Liu, Yong-Wen Song, Hui Fang, Hua Ren, Ning-Ning Lu, Qingfeng Liu, Runye Wu, Ximei Zhang, Xin-Fan Liu, Zihao Yu	8
19	Variable Clinical Presentations of Nasal and Waldeyer Ring Natural Killer/T-Cell Lymphoma 2009 ·Clinical Cancer Research ·Ye‐Xiong Li, (unknown), Hui Fang, Shunan Qi, Hua Wang, Weihu Wang, (unknown), Jiade J. Lu, Jing Jin, Shulian Wang, Yueping Liu, Ning Lü, Xin-Fan Liu, Zihao Yu	85
20	The role of postmastectomy radiotherapy in breast cancer patients with T 1 -T 2 and one to three positive axillary nodes 2009 ·Zhonghua fangshe zhongliuxue zazhi ·Shulian Wang, Zihao Yu, Ye‐Xiong Li, Yuan Tang, Shunan Qi, Jianzhong Cao, Wenqing Wang, Tao Li, Jing Jin, Weihu Wang, Yongwen Song, Yueping Liu, Xin-Fan Liu	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact